TL;DR: The Centers for Medicare & Medicaid Services modified NCD 229, the National Coverage Determination governing Medicare coverage of Intrapulmonary Percussive Ventilators for home use, effective March 7, 2026. The policy maintains a blanket non-coverage determination for IPV in the home setting. This policy lists no specific HCPCS or CPT codes. If your DME billing team submits claims for home IPV under Medicare, expect denial — and update your workflows accordingly before March 7, 2026.


Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Intrapulmonary Percussive Ventilator (IPV)
Policy Code NCD 229
Change Type Modified
Effective Date 2026-03-07
Impact Level High — blanket non-coverage for home IPV under Medicare
Specialties Affected Pulmonology, Respiratory Therapy, DME Suppliers, Home Health
Key Action Remove or flag home IPV claims in your Medicare charge capture before March 7, 2026 — these will not reimburse

CMS Intrapulmonary Percussive Ventilator Coverage Criteria and Medical Necessity Requirements 2026

CMS's position on IPV in the home setting is unambiguous: there is no covered indication. NCD 229 is the National Coverage Determination that governs Medicare reimbursement for Intrapulmonary Percussive Ventilators, and the 2026 modified version does not soften that position at all.

IPV is a mechanized form of chest physical therapy. Rather than manual chest clapping from a therapist, the device delivers more than 200 mini-bursts of respiratory gas per minute via mouthpiece, with the intent of mobilizing endobronchial secretions and diffusing patchy atelectasis. The patient controls inspiratory time, peak pressure, and delivery rates. On paper, it sounds clinically plausible — the problem is the evidence.

CMS's coverage policy conclusion is direct: studies do not demonstrate any advantage of IPV over standard pulmonary care in the hospital setting, and there are no studies at all in the home setting. No data, no coverage. That's the medical necessity bar Medicare is holding, and it's a hard stop for home claims.

If you're hoping a diagnosis code or a letter of medical necessity gets this through, don't. This isn't a prior authorization situation where the right documentation unlocks coverage. It's a national non-coverage determination — meaning no prior auth pathway exists at the home setting level under Medicare. The claim will deny regardless of documentation.


CMS Intrapulmonary Percussive Ventilator Exclusions and Non-Covered Indications

The entire home-setting use case is the exclusion here. CMS doesn't carve out specific patient populations or diagnoses for non-coverage — it covers none of them. Every indication, every diagnosis, every patient type: if the IPV is in the home setting, Medicare will not reimburse.

The rationale is evidentiary, not clinical. CMS isn't saying IPV is harmful. They're saying the evidence base to support home IPV reimbursement doesn't exist. That distinction matters if you're advising a physician who believes clinically in the device — the payer's objection isn't to the mechanism, it's to the absence of outcomes data in the home environment.

The hospital setting isn't explicitly addressed in this NCD as a coverage context — but the language notes even hospital-setting studies show no advantage over good standard pulmonary care. That's a signal that coverage in any setting under Medicare is a long shot, not just at home.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
IPV use in home setting — endobronchial secretion mobilization Not Covered No codes listed in policy Blanket non-coverage under NCD 229; no prior auth pathway
IPV use in home setting — patchy atelectasis treatment Not Covered No codes listed in policy No supporting outcome data in home setting per CMS review

This policy is now in effect (since 2026-03-07). Verify your claims match the updated criteria above.

CMS Intrapulmonary Percussive Ventilator Billing Guidelines and Action Items 2026

#Action Item
1

Audit your Medicare DME charge capture before March 7, 2026. Pull any active or pending charges associated with home IPV. If your system uses HCPCS codes for chest physiotherapy devices or ventilatory support equipment, cross-check whether any of those lines are being used for home IPV claims under Medicare. The policy lists no codes, but your billing team likely has internal mappings — verify them now.

2

Do not submit home IPV claims to Medicare expecting reimbursement. NCD 229 is a national determination. It applies to all Medicare contractors uniformly. There is no jurisdiction where a home IPV claim will be adjudicated differently. If you've been submitting these claims hoping for a MAC-level favorable local policy, that's not a viable strategy here.

3

Flag any advance beneficiary notices (ABNs) that may be in use. If your practice or DME supplier is issuing ABNs for home IPV to transfer financial liability to the patient, confirm your ABN language is current and legally sound. An ABN doesn't create coverage — it creates a paper trail for patient liability. Make sure patients understand the device won't be covered under Medicare before March 7, 2026, not after they've received it.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Intrapulmonary Percussive Ventilator Under NCD 229

The 2026 version of NCD 229 does not list specific CPT codes, HCPCS codes, or ICD-10-CM diagnosis codes in the policy document. This is worth noting for your billing team because it means CMS is applying a blanket non-coverage rule rather than tying the exclusion to specific code-level submissions.

No Policy-Listed Codes

Code Type Status
CPT No codes listed in NCD 229
HCPCS No codes listed in NCD 229
ICD-10-CM No codes listed in NCD 229

The absence of codes doesn't reduce your denial risk — it increases your documentation burden. When a policy doesn't enumerate specific codes, claims reviewers rely on service descriptions, clinical notes, and device identifiers to flag the service. Your billing team should not interpret "no codes listed" as ambiguity about coverage. It's non-coverage, full stop, for home IPV under Medicare.

If your MAC or clearinghouse has published local guidance mapping specific HCPCS codes to IPV claims (for example, codes in the E-series for DME respiratory equipment), those mappings remain your team's responsibility to track. CMS's national policy doesn't codify them, but your local contractor's claims processing instructions may. Review those instructions separately.


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee